Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …

Hepatocellular Carcinoma (HCC) continues to pose a substantial global health challenge
due to its high incidence and limited therapeutic options. In recent years, the Janus Kinase …

Liver cancer is the second most lethal cancer in the world with limited treatment options.
Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has …

Liver cancer (LC) poses a significant global health challenge due to its high incidence and
poor prognosis. Current systemic treatment options, such as surgery, chemotherapy …

Hepatocellular carcinoma (HCC) is an aggressive tumour with limited treatment options. The
Janus kinase/signal transducers and activators of transcription (JAK/STAT) signalling …

Liver cancer is a leading cause of cancer death, making it as the second most common
cause for death from cancer globally. Though many studies before have explored a lot for …

The Janus kinase 1 (JaK1) gene encodes a cytoplasmic tyrosine kinase that is
noncovalently associated with a variety of cytokine receptors and plays a nonredundant role …

Hepatocellular carcinoma is an end-stage complication of non-alcoholic fatty liver disease
(NAFLD). Inflammation plays a critical role in the progression of non-alcoholic fatty liver …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. It
can be caused by chronic liver cell injury with resulting sustained inflammation, eg, triggered …

Hepatocellular carcinoma (HCC) is one the most common malignancies and has poor
prognosis in patients. The aim of the present study is to explore the clinical significance of …